PDL BioPharma Seeks Ularitide Partner That Grants Rights To A Late-Stage Drug

A more complicated partnership involving two clinical programs is taking more time to complete than a “ularitide-only” deal, the biotech says.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet